Patent Issued for Antibody variable domains targeting the NKG2D receptor (USPTO 12129300)

MLA

“Patent Issued for Antibody Variable Domains Targeting the NKG2D Receptor (USPTO 12129300).” Cancer Weekly, 19 Nov. 2024, p. 787. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.816420888&authtype=sso&custid=ns315887.

APA

Patent Issued for Antibody variable domains targeting the NKG2D receptor (USPTO 12129300). (2024, November 19). Cancer Weekly, 787.

Chicago

Cancer Weekly. 2024. “Patent Issued for Antibody Variable Domains Targeting the NKG2D Receptor (USPTO 12129300),” November 19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.816420888&authtype=sso&custid=ns315887.